Nasal Muco-ciliary Clearance Study With and Without Salt Inhalation
NCT04189016 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 31
Last updated 2021-01-15
Summary
Investigating nasal muco-ciliary clearance by scintigraphy
Conditions
- Obstructive Airway Diseases
Interventions
- DEVICE
-
Inhalation from a salt particle inhaler with or without content
Inhalation from inhaler with (active) or without (placebo) content
Sponsors & Collaborators
-
Liita Care ApS
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- DOUBLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-02-28
- Primary Completion
- 2021-08-31
- Completion
- 2021-09-30
Countries
- Denmark
Study Locations
More Related Trials
-
A Study of Inhalation of 20,000 EU CCRE and Mucociliary Clearance (MCC) in Otherwise Healthy Individuals Who Are Current Cigarette Smokers
NCT00924768 ·Status: COMPLETED ·Phase: PHASE1
-
Hypertonic Saline Inhalation for Mycobacterium Avium Complex Pulmonary Disease
NCT05192057 ·Status: RECRUITING ·Phase: PHASE4
-
A Study to Test the Safety and Effects of Inhaled GDC-6988 in Participants With Muco-obstructive Disease
NCT06603246 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Study in Healthy Adults to Quantify Lung Deposition and Distribution of Radio-labelled S-770108 Inhalation Powder Formulation Delivered by a Novel Inhaler Device
NCT04631354 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy of Bronchitol in Bronchiectasis
NCT00277537 ·Status: COMPLETED ·Phase: PHASE3
-
Monitoring Metered Dose Inhalation (MDI) Volume and Timing With a Respimetrix Device in Obstructive Lung Disease.
NCT05495256 ·Status: COMPLETED ·Phase: NA
-
Novel Therapies for Muco-Obstructive Lung Diseases: Testing the Transnasal Pulmonary Delivery Device in COPD/CB Subjects
NCT02341183 ·Status: WITHDRAWN ·Phase: NA
-
Efficacy of Breathox Device Inhalation Therapy in the Treatment of Acute Symptoms Associated With COVID-19 and in the Prevention of the Use of Health Resources
NCT05196581 ·Status: COMPLETED ·Phase: PHASE2
-
COmmunity Patients at Risk of Viral Infections Including SARS-CoV-2
NCT04858451 ·Status: TERMINATED ·Phase: PHASE2
-
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
NCT01857323 ·Status: COMPLETED ·Phase: PHASE3
-
Sputum Clearance Effects of Hypertonic Saline in Non-cystic Fibrosis Bronchiectasis
NCT02392663 ·Status: COMPLETED ·Phase: NA
-
Inspiratory Flow and Volumes in Bronchiectatics
NCT00656565 ·Status: COMPLETED
-
Study of the AeriSeal System for HyPerInflation Reduction in Emphysema (ASPIRE)
NCT01449292 ·Status: TERMINATED ·Phase: PHASE3
-
Study to Assess CSL787 in Non-cystic Fibrosis Bronchiectasis (NCFB)
NCT04643587 ·Status: COMPLETED ·Phase: PHASE1
-
A Study Evaluating the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of SM04646 Inhalation Solution in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
NCT03591926 ·Status: WITHDRAWN ·Phase: PHASE2
-
Comparison of Viral Particle Dispersion Following Administration of an MDI or Nebulizer in Subjects With COVID-19
NCT04681079 ·Status: COMPLETED
-
Evaluation of the Diagnostic Utility of INS316 in Patients With Interstitial Lung Diseases (01-701)
NCT01381666 ·Status: TERMINATED ·Phase: PHASE2
-
A Study to Assess the Effect of AZD5634 on Mucociliary Clearance, Safety, Tolerability and Pharmacokinetic Parameters in Patients With Cystic Fibrosis
NCT02950805 ·Status: COMPLETED ·Phase: PHASE1
-
Sodium Pyruvate Therapy in COPD Patients
NCT00262613 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase 1 Study to Characterize the Effect of GS-5737 Enhancement of Mucociliary Clearance (MCC) in Healthy Subjects
NCT01793649 ·Status: TERMINATED ·Phase: PHASE1
-
Study of the AeriSeal System Treatment in Patients With Advanced Non-Upper Lobe Predominant Heterogeneous Emphysema
NCT01908933 ·Status: WITHDRAWN ·Phase: PHASE3
-
Long-term, Open-label Study of SAR447537 (INBRX-101) in Adults With Alpha-1 Antitrypsin Deficiency Emphysema
NCT05897424 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Study to Assess CMR316 in Healthy Volunteers and Patients With Idiopathic Pulmonary Fibrosis
NCT06589219 ·Status: RECRUITING ·Phase: PHASE1
-
Explorative Clinical Investigation to Investigate the Ability of PreciseInhale to Direct Regional Lung Targeting and Reduce the Degree of Throat Deposition and Subsequent Gastrointestinal Absorption in Healthy Volunteers After Inhalation of Test Drug Substances Via the PreciseInhale System
NCT04946630 ·Status: COMPLETED ·Phase: NA
-
PulseHaler Drug Deposition Study in Chronic Obstructive Pulmonary Disease Patients
NCT01187589 ·Status: COMPLETED ·Phase: NA